T he metabolic syndrome is associated with increased cardiovascular morbidity and mortality (1,2). In 2005, the International Diabetes Federation (IDF) formulated a new, clinically accessible worldwide definition of the metabolic syndrome in a global consensus statement (3) built on earlier definitions (4, 5) .
According to the IDF, central obesity is an essential component of the metabolic syndrome. Moreover, central obesity must be determined by ethnicity-and sex-specific cutoff values for waist circumference. The IDF also sets the cutoff value for raised fasting plasma glucose concentration at 100 mg/dl, which is 10 mg/dl lower than that of the NCEP ATP III (National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, Adult Treatment Panel III) (5). In agreement with the IDF proposal, the Korean Society for the Study of Obesity defined the cutoff values of waist circumference for central obesity among Korean adults as 90 cm for men and 85 cm for women (6).
There is insufficient data about the prevalence of the metabolic syndrome according to the new worldwide definition proposed by the IDF. We therefore assessed the prevalence of the metabolic syndrome according to IDF criteria, using ethnicity-and sex-specific cutoff values for central obesity.
RESEARCH DESIGN AND METHODS -The Korean Ministry of
Health and Welfare conducted the Korean National Health and Nutrition Examination Survey in noninstitutionalized Korean civilians in 1998. A stratified multistage probability sampling design was used. Of 8,465 participants, data from subjects younger than 20 years (n ϭ 1,542) and older than 80 years (n ϭ 99) of age were excluded, leaving data from 6,824 respondents available for analysis. Anthropometric parameters and blood pressures were measured by standard methods. Plasma glucose, total cholesterol, triglycerides, and HDL cholesterol were analyzed at a central, certified laboratory.
Adopting IDF criteria (3), the metabolic syndrome in South Korean adults was defined by central obesity (waist circumference Ն90 cm for men and Ն85 cm for women) (6) plus two of the following four factors: serum triglyceride Ն150 mg/ dl, HDL cholesterol Ͻ40 mg/dl for men and Ͻ50 mg/dl for women, systolic blood pressure Ն130 mmHg or diastolic blood pressure Ն85 mmHg, and fasting plasma glucose Ն100 mg/dl. Statistical analysis was conducted using SAS Version 8.1. All analyses were two-tailed, and a P value Ͻ0.05 was considered statistically significant.
RESULTS -The age-adjusted prevalence of each component of the metabolic syndrome and the clustering of metabolic components are shown in Table 1 . The age-adjusted prevalence of the metabolic syndrome was 13.5% in men and 15.0% in women. The age-adjusted prevalence of central obesity, defined as a waist circumference of Ն90 cm for Korean men and Ն85 cm for Korean women, was 19.4% in men and 22.5% in women. Elevated serum triglyceride concentrations were detected in 35% of men and 20% of women, low HDL cholesterol was observed in 25% of men and 46.2% of women, elevated blood pressure was detected in 44.2% of men and 29% of women, and increased fasting plasma glucose concentration or previously diagnosed type 2 diabetes was observed in 39.1% of men and 34.6% of women. The age-adjusted prevalence of central obesity plus any one, two, three, or four metabolic components was 17.9, 13.5, 7.1, and 1.7%, respectively, in Korean men, and 20.5, 15.0, 7.5, and 2.4%, respectively, in Korean women. Under age 50 years, the prevalence of the metabolic syndrome was higher in men than in women, but this was reversed among participants over age 50 years. In both men and women, the prevalence of the metabolic syndrome significantly increased linearly with BMI.
CONCLUSIONS -Using IDF criteria (3), the prevalence of the metabolic syndrome was 13.5% for Korean men and 15.0% for Korean women. This was similar to the results seen using the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, Adult Treatment Panel III criteria, which found that the prevalence of the metabolic syndrome was 14.2% for Ko-rean men and 17.7% for Korean women (7).
A prominent feature of the IDF definition of the metabolic syndrome is that central obesity is an essential, not an optional, component of the metabolic syndrome (3), with recommendations for central obesity defined according to ethnicity-specific values of waist circumference (5,8 -10). The Korean Society for the Study of Obesity defined the cutoff values of waist circumference for central obesity in Koreans as Ն90 cm for men and Ն85 cm for women based on analysis of representative data (6). Using these ethnicityspecific cutoff values of waist circumference, the prevalence of central obesity was ϳ20% in both Korean men and women.
Another feature of the IDF criteria for the metabolic syndrome is the cutoff value for fasting plasma glucose Ն100 mg/dl, which is 10 mg/dl lower than the cutoff value of the NCEP ATP III. Among Koreans, the prevalence of raised fasting plasma glucose, defined as Ն100 mg/dl, was 39.1% for men and 34.6% for women. However, only 2.3% of the Korean population was obese, as defined by BMI Ն30 kg/m 2 . In conclusion, our study showed that using IDF criteria, the prevalence of the metabolic syndrome among Korean adults was 13.5% for men and 15.0% for women. Using ethnicity-specific cutoff values for waist circumference, the prevalence of central obesity was ϳ20% in both men and women. Our findings suggest the need to apply ethnicity-specific cutoff values for waist circumference to assess the metabolic syndrome. Data are means Ϯ SD or percent. *The metabolic syndrome was defined in South Korean adults as central obesity (waist circumference Ն90 cm for men and Ն85 cm for women) plus two of the following four factors: serum triglyceride Ն150 mg/dl (Ն1.7 mmol/l) or specific treatment for this lipid abnormality, HDL cholesterol Ͻ40 mg/dl (Ͻ1.03 mmol/l) for men and Ͻ50 mg/dl (Ͻ1.29 mmol/l) for women or specific treatment for this lipid abnormality, systolic blood pressure Ն130 mmHg or diastolic blood pressure Ն85 mmHg or treatment of previously diagnosed hypertension, and fasting plasma glucose Ն100 mg/dl (Ն5.6 mmol/l) or previously diagnosed type 2 diabetes.
